Replies to post #818791 on NorthWest Biotherapeutics Inc (NWBO)

[branster]

Baxers, excellent research, I missed the 3 CHM meeting and had only assumed two meeting took place. All your timelines setup perfectly, I will be watching how trading transpires into April assuming no deciion by then.

[10baggerz]

I agree with your timing analysis. One thing I would add is the ECA guidance timing.
Obviously the MHRA CAN approve before the final guidance is released, but with this being a first-of-its-kind approval (external controls + a personalized cell therapy), MHRA may  to wait until the new framework is in place to protect themselves and make DCVax the first approval clearly operating under the new rules.NWBO basically stated this in their June 30, 2025 10-Q:If the science was effectively settled at the Nov 2025 CHM, it wouldn't be surprising if the final administrative step lines up with the April 28, 2026 (or before) ECA guidance effective date.Your CHM timing comps + this regulatory timing both point to the same window and I don’t think that it is a coincidence That the MHRA is taking all of its statutorily allotted time. Maybe NWBO itself, or at least GZ in his comments to me and other shareholders about being MORE FRUSTRATED THAN ANYONE, doesn’t realize that the MHRA is essentially stalling until final ECA guidance is released.GLTA

[Flexroy]

This datum needs to be shared more widely. Investors should be very excited for April